These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31734986)

  • 21. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
    Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
    Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B.
    Yi W; Pan CQ; Li MH; Wan G; Lv YW; Liu M; Hu YH; Zhang ZY; Xie Y
    Am J Gastroenterol; 2018 May; 113(5):686-693. PubMed ID: 29487412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of liver biopsy on the decision to treat patients with chronic hepatitis B genotype D virus infection.
    Al-Qahtani AA; Al-Ashgar HI; Al Mana H; Al-Ahdal MN; Soliman Ali A; Hasanain AF; Helmy A
    Intervirology; 2014; 57(5):248-53. PubMed ID: 24993859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
    Chien RN; Liaw YF; Atkins M
    Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management.
    Chang ML; Liaw YF
    J Hepatol; 2014 Dec; 61(6):1407-17. PubMed ID: 25178562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of granulocyte-macrophage colony-stimulating factor or lamivudine combination with recombinant interferon in non-responders to interferon in hepatitis B virus-related chronic liver disease patients.
    Guptan RC; Thakur V; Kazim SN; Sarin SK
    J Gastroenterol Hepatol; 2002 Jul; 17(7):765-71. PubMed ID: 12121506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
    You H; Wu X; Ou X; Ma H; Wang Q; Liu T; Cong M; Wang P; Wang B; Jia J
    Antivir Ther; 2011; 16(3):299-307. PubMed ID: 21555812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.
    Chang Y; Choe WH; Sinn DH; Lee JH; Ahn SH; Lee H; Shim JJ; Jun DW; Park SY; Nam JY; Cho EJ; Yu SJ; Lee DH; Lee JM; Kim YJ; Kwon SY; Paik SW; Yoon JH
    J Infect Dis; 2017 Dec; 216(11):1407-1414. PubMed ID: 29029102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.
    Yao G; Cui Z; Wang B; Yao J; Zeng M
    Chin Med J (Engl); 2002 Dec; 115(12):1814-8. PubMed ID: 12622930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum alanine aminotransferase flares during interferon treatment of chronic hepatitis B: is sustained clearance of HBV DNA dependent on levels of pretreatment viremia?
    Nair S; Perrillo RP
    Hepatology; 2001 Nov; 34(5):1021-6. PubMed ID: 11679974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis B.
    Wong GL; Chan HL; Tse YK; Yip TC; Lam KL; Lui GC; Wong VW
    J Hepatol; 2018 Oct; 69(4):793-802. PubMed ID: 29758335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
    Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
    Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
    Tai DI; Lin SM; Sheen IS; Chu CM; Lin DY; Liaw YF
    Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH; Kim YM; Kim SG
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):778-86. PubMed ID: 22943930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Optimal timing of antiviral therapy for chronic HBV-infected patients with normal ALT].
    Gui HL; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2020 Dec; 28(12):988-991. PubMed ID: 34865343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
    Lu JF; Liu YL; Ma LN; Cao ZH; He ZM; Jin Y; Zhang SB; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2015 Nov; 23(11):821-5. PubMed ID: 26743241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.